Full text
PDF![633](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c4/436019/8a07ac0fe41f/jcinvest00735-0116.png)
![634](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c4/436019/38915779dc0a/jcinvest00735-0117.png)
![635](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c4/436019/b81f117a6528/jcinvest00735-0118.png)
![636](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c4/436019/bd5e5c627b00/jcinvest00735-0119.png)
![637](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c4/436019/6419390fb56b/jcinvest00735-0120.png)
![638](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c4/436019/fbb934a89076/jcinvest00735-0121.png)
![639](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c4/436019/998e8a780f37/jcinvest00735-0122.png)
![640](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c4/436019/6e946c298876/jcinvest00735-0123.png)
![641](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c4/436019/ad287631f331/jcinvest00735-0124.png)
![642](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c4/436019/6ab07a25a985/jcinvest00735-0125.png)
![643](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c4/436019/a22182686b47/jcinvest00735-0126.png)
![644](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c4/436019/c15c137e6d88/jcinvest00735-0127.png)
![645](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c4/436019/a881db0d964b/jcinvest00735-0128.png)
![646](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c4/436019/ae88137d728b/jcinvest00735-0129.png)
![647](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c4/436019/2fc0e8ba9bd1/jcinvest00735-0130.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Finland M., Winkler A. W. ANTIBODY RESPONSE TO INFECTIONS WITH TYPE III AND THE RELATED TYPE VIII PNEUMOCOCCUS. J Clin Invest. 1934 Jan;13(1):79–95. doi: 10.1172/JCI100580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robertson O. H., Graeser J. B., Coggeshall L. T., Harrison M. A. THE RELATION OF CIRCULATING ANTIPNEUMOCOCCAL IMMUNE SUBSTANCES TO THE COURSE OF LOBAR PNEUMONIA I. NATURAL IMMUNE SUBSTANCES. J Clin Invest. 1934 Jul;13(4):621–631. doi: 10.1172/JCI100610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sutliff W. D., Rhoades D. R. THE PNEUMOCOCCIDAL POWER OF WHOLE BLOOD: II. Estimations in Lobar Pneumonia. J Clin Invest. 1930 Aug;9(1):55–68. doi: 10.1172/JCI100294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Terrell E. E., Robertson O. H., Coggeshall L. T. EXPERIMENTAL PNEUMOCOCCUS LOBAR PNEUMONIA IN THE DOG : I. Method of Production and Course of the Disease. J Clin Invest. 1933 Mar;12(2):393–432. doi: 10.1172/JCI100510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Trask J. D., O'donovan C., Moore D. M., Beebe A. R. STUDIES ON PNEUMONIA IN CHILDREN: I. Mortality, Blood Cultures, and Humoral Antibodies in Pneumococcus Pneumonia. J Clin Invest. 1930 Jun;8(4):623–653. doi: 10.1172/JCI100284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Winkler A. W., Finland M. ANTIBODY RESPONSE TO INFECTIONS WITH THE NEWLY CLASSIFIED TYPES OF PNEUMOCOCCI (COOPER). J Clin Invest. 1934 Jan;13(1):109–120. doi: 10.1172/JCI100571. [DOI] [PMC free article] [PubMed] [Google Scholar]